June 27, 2022 — Christina Herrin
The FDA’s decision to stop Juul from selling e-cigarette products in the U.S. will harm public health.
June 27, 2022 — Christina Herrin 1656332224
June 23, 2022 — Christina Herrin
Increasing regulations on pharmacy benefit managers will not reduce the cost of pharmaceuticals.
June 23, 2022 — Christina Herrin 1656004297
The op-ed concludes that drug importation will risk public health and do little to lower drug prices.
June 1, 2022 — Christina Herrin
Tobacco harm reduction products like e-cigarettes are effective tools that help adults successfully quit smoking.
June 1, 2022 — Christina Herrin 1654091974
SB 32 would impede and restrict pharmacy audits.
H. 353 would further insert the state government into healthcare by micromanaging pharmacy benefit managers.
Conferees should strike all language related to the Prescription Drug Affordability Board and drug price controls from SF 4410.
